|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
150+ minutes | 1-149 minutes | 0 minutes | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 5,999 | 2,960 | 48.1 | 46.6-49.7 | 1,295 | 23.1 | 21.8-24.5 | 1,744 | 28.7 | 27.3-30.2 |
| GENDER | ||||||||||
| Male | 2,559 | 1,310 | 49.6 | 47.3-52.0 | 542 | 22.6 | 20.6-24.6 | 707 | 27.8 | 25.7-30.0 |
| Female | 3,440 | 1,650 | 46.8 | 44.7-48.8 | 753 | 23.7 | 21.9-25.5 | 1,037 | 29.6 | 27.7-31.5 |
| Have Health Insurance | ||||||||||
| Yes | 5,217 | 2,656 | 49.5 | 47.9-51.2 | 1,094 | 22.9 | 21.5-24.3 | 1,467 | 27.6 | 26.1-29.1 |
| No | 767 | 296 | 39.9 | 35.7-44.3 | 200 | 25.2 | 21.6-29.2 | 271 | 34.9 | 31.0-39.1 |
| Body Mass Index | ||||||||||
| Underweight | 84 | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 1,731 | 1,018 | 55.9 | 53.0-58.8 | 344 | 22.8 | 20.4-25.4 | 369 | 21.3 | 19.0-23.8 |
| Overweight | 2,030 | 1,036 | 49.5 | 46.9-52.1 | 440 | 23.0 | 20.8-25.3 | 554 | 27.5 | 25.2-29.9 |
| Obese | 1,670 | 682 | 41.2 | 38.3-44.2 | 384 | 23.6 | 21.2-26.3 | 604 | 35.2 | 32.3-38.1 |
| Current Smoker | ||||||||||
| Yes | 999 | 399 | 40.2 | 36.5-44.0 | 190 | 20.9 | 17.8-24.4 | 410 | 38.9 | 35.3-42.7 |
| No | 4,967 | 2,550 | 50.0 | 48.3-51.7 | 1,098 | 23.7 | 22.3-25.2 | 1,319 | 26.2 | 24.8-27.8 |
| History of CVD** | ||||||||||
| Yes | 677 | 293 | 41.7 | 37.3-46.3 | 117 | 18.9 | 15.5-22.7 | 267 | 39.4 | 34.9-44.0 |
| No | 5,276 | 2,655 | 48.9 | 47.3-50.6 | 1,171 | 23.6 | 22.2-25.1 | 1,450 | 27.5 | 26.0-29.0 |
| Binge Drinker | ||||||||||
| Yes | 688 | 350 | 52.1 | 47.8-56.4 | 173 | 26.1 | 22.4-30.1 | 165 | 21.8 | 18.5-25.4 |
| No | 5,122 | 2,522 | 47.6 | 45.9-49.3 | 1,086 | 22.8 | 21.4-24.2 | 1,514 | 29.6 | 28.1-31.2 |
| Heavy Drinker | ||||||||||
| Yes | 270 | 141 | 55.2 | 48.1-62.1 | 63 | 21.9 | 16.7-28.1 | 66 | 22.9 | 17.6-29.2 |
| No | 5,530 | 2,725 | 47.9 | 46.3-49.5 | 1,192 | 23.3 | 21.9-24.7 | 1,613 | 28.8 | 27.3-30.3 |
| COPD | ||||||||||
| Yes | 502 | 170 | 31.2 | 26.4-36.4 | 93 | 20.1 | 16.0-25.0 | 239 | 48.7 | 43.2-54.2 |
| No | 5,472 | 2,781 | 49.6 | 47.9-51.2 | 1,199 | 23.4 | 22.1-24.9 | 1,492 | 27.0 | 25.6-28.5 |
| Current Asthma | ||||||||||
| Yes | 504 | 195 | 38.7 | 33.4-44.2 | 116 | 24.9 | 20.2-30.3 | 193 | 36.4 | 31.3-41.8 |
| No | 5,467 | 2,754 | 49.0 | 47.3-50.6 | 1,173 | 23.0 | 21.7-24.4 | 1,540 | 28.0 | 26.6-29.5 |
| Diabetes | ||||||||||
| Yes | 754 | 289 | 37.5 | 33.5-41.6 | 145 | 20.4 | 17.2-24.1 | 320 | 42.1 | 37.9-46.4 |
| No | 5,239 | 2,669 | 49.4 | 47.7-51.0 | 1,149 | 23.4 | 22.0-24.9 | 1,421 | 27.2 | 25.7-28.7 |
| Disability | ||||||||||
| Yes | 1,605 | 591 | 35.9 | 33.0-38.8 | 310 | 20.7 | 18.3-23.2 | 704 | 43.5 | 40.5-46.5 |
| No | 4,374 | 2,361 | 52.1 | 50.3-53.9 | 982 | 23.9 | 22.4-25.6 | 1,031 | 23.9 | 22.4-25.5 |
| Has two or more chronic diseases† | ||||||||||
| Yes | 1,847 | 763 | 38.5 | 35.9-41.3 | 347 | 20.4 | 18.2-22.8 | 737 | 41.1 | 38.3-43.9 |
| No | 4,152 | 2,197 | 51.6 | 49.7-53.4 | 948 | 24.1 | 22.6-25.8 | 1,007 | 24.3 | 22.7-25.9 |
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2015 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2015 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 28SEP16.
FOLLOW US